Trial intelligence / Profile preview

Dopamine Modulation in Fibromyalgia Pain Processing

NCT04674670Completed

Start
Nov 2021
Primary completion
Jul 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of bromocriptine in fibromyalgia (FM) (2 arms). Primary endpoints: Blood oxygen level dependent responses, Sensory pain responses and 1 more. Started Nov 2021; status: completed.

02

Drugs

bromocriptine
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT04674670.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04674670.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call